Regeneron Pharmaceuticals Inc (REGN) Options Trading Heats Up on Drug Data

Option volume on Regeneron Pharmaceuticals Inc (REGN) is on track for a yearly high after the company reported promising drug results

Apr 1, 2016 at 10:51 AM
facebook X logo linkedin


Drugmaker Regeneron Pharmaceuticals Inc (NASDAQ:REGN) is up 5.8% to $381.32 today on news that its eczema drug, dupilumab -- a joint venture with Sanofi SA (ADR) (NYSE:SNY) -- showed positive results in two Phase 3 trials. And as the stock makes its biggest upward move in a month, action is heating up in the REGN option pits.

So far today, REGN options are trading at six times their average intraday rate, with calls outnumbering puts by about 2-to-1. In fact, with 2,806 calls and 1,386 puts exchanged so far today, option volume is currently on pace to approach a total of 16,000 contracts -- which would represent a new annual high for the drug stock.

Average daily volume on REGN options tends to be light -- but today's trend toward calls over puts is more of the same. In fact, the security has a Schaeffer's put/call open interest ratio (SOIR) of 0.87 -- which ranks lower than 100% of the past year's worth of readings, as near-term options traders are more call-skewed now than at any other time in the past 12 months.

REGN shares are still down nearly 30% year-to-date -- due in part to poorly received earnings in early February -- and traders who were betting on a bigger rebound may be disappointed. Even with today's bounce, REGN remains under pressure from its descending 40-day moving average. In fact, the stock is currently attempting to close above this trendline for the first time since mid-December.

But Regeneron Pharmaceuticals Inc (NASDAQ:REGN) could get some help challenging this trendline resistance if analysts come around in light of today's news. Specifically, 11 brokerage firms -- more than half of those providing coverage -- rate the stock a "hold" or "strong sell."

Sign up now for Schaeffer's Market Recap to get all the day's big stock movers, must-know technical  levels, and top economic stories straight to your inbox.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI